Key result
Implantable cardioverter-defibrillator therapy can provoke or worsen cardiac arrhythmias, a risk that can be minimized by tailoring device programming to individual patient characteristics.
Population
High-risk patients receiving implantable cardioverter-defibrillators
Design
Review
Authors
Loading...
Supports tailored ICD programming to mitigate proarrhythmic risk; leaves open optimal strategies by patient subgroup.
While effective in preventing sudden cardiac death, ICDs carry a proarrhythmic potential that requires careful, individualized programming to minimize morbidity.
Pinski et al. (1995) conducted a review in High-risk patients at risk of sudden cardiac death. Implantable cardioverter-defibrillator (ICD) was evaluated. Implantable cardioverter-defibrillator therapy can provoke or worsen cardiac arrhythmias, a risk that can be minimized by tailoring device programming to individual patient characteristics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: